<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
<channel>
	<title>Stellar Biotechnologies News Releases</title>
	<link>http://www.stellarbiotechnologies.com/investors/news_releases/</link>
	<description>Stellar Biotechnologies News Releases</description>
	<pubDate>Fri, 10 Feb 2012 16:38:55 -08:00thPST</pubDate>
    
	<language>en</language>
		
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/StellarBiotechnologiesNewsReleases" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="stellarbiotechnologiesnewsreleases" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
    <title>Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce that it will be making two presentations at the Biotech Showcase 2012 Conference in San Francisco Jan...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=91</link>
    <pubDate>Wed, 04 Jan 2012 20:03:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Adopts Shareholder Rights Plan</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) (U.S. OTC: SBOTF) ("Stellar" or the "Company") is pleased to announce that it has adopted a shareholder rights plan (the "Rights Plan") designed to encour...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=90</link>
    <pubDate>Tue, 20 Dec 2011 08:34:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery &amp; Sera Production Capability</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. ("Stellar") (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce the completion of a major expansion of its keyhole limpet (megathura crenulata) hatchery facility in ...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=89</link>
    <pubDate>Tue, 06 Dec 2011 06:03:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Featured in National Cancer Institute (NCI) Success Story and Popular Science Magazine Article</title>
    <description><![CDATA[PORT HUENEME, CA--(Marketwire - November 22, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to report two recent news stories on the company, by the Nat...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=88</link>
    <pubDate>Tue, 22 Nov 2011 14:00:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies to Submit Documents for Registration of Shares in the U.S.</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce they have retained A.B. Korelin &amp; Associates Inc. of Blaine, WA to assist the Company in its preparatio...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=87</link>
    <pubDate>Wed, 02 Nov 2011 09:14:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies &amp; Life Diagnostics Announce Agreement for Stellar Brand KLH ELISA Test Kits</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) and Life Diagnostics, Inc. are pleased to announce they have entered into an exclusive manufacturing and supply agreement. Lif...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=86</link>
    <pubDate>Wed, 26 Oct 2011 15:19:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces Receipt of Lead Purchase Order</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce they have received the first purchase order from Sigma-Aldrich under terms of the marketing agreement b...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=84</link>
    <pubDate>Tue, 20 Sep 2011 06:27:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces Retention of LifeTech Capital for Strategic Business Planning</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V:
KLH) (U.S. OTC: SBOTF) is pleased to announce they have entered into an agreement for
strategic business planning advisory services with LifeTech C...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=83</link>
    <pubDate>Mon, 12 Sep 2011 20:26:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant</title>
    <description><![CDATA[PORT HUENEME, CA-- August 29, 2011 - Stellar Biotechnologies, Inc. "Stellar" (TSX-V:KLH) (U.S. OTC: SBOTF) is pleased to announce that the National Science Foundation (NSF) has granted Stellar a Ph...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=82</link>
    <pubDate>Mon, 29 Aug 2011 15:18:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces a Strategic Agreement for Marketing and
Sales with SAFC&amp;copy;</title>
    <description><![CDATA[PORT HUENEME, CA (August 3, 2011) -- Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH)
(U.S. OTC: SBOTF) is pleased to announce they have entered into an agreement for marketing
and sales with...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=81</link>
    <pubDate>Wed, 03 Aug 2011 16:36:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Presents Phase IIB Proposal to The U.S. National Science Foundation (NSF)</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (U.S. OTC: SBOTF) is pleased to announce that its President, Frank Oakes and Executive VP, Corporate Development &amp; Finance, Darrell Brookstein r...]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/nr_2011_07_06.pdf</link>
    <pubDate>Wed, 06 Jul 2011 04:42:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Releases Semi-Annual President's Letter to
Shareholders</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. "Stellar" (TSX-V:
KLH) (U.S. OTC: SBOTF) is pleased to announce that its semi-annual CEO Letter to
Shareholders has been released.]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/nr_2011_06_13.pdf</link>
    <pubDate>Mon, 13 Jun 2011 13:54:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces Appointment of New Director, 
David L. Hill, Ph. D.</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) 
(U.S. OTC: SBOTF) is very pleased to announce that it has appointed David L. Hill, 
Ph.D. as a member of its board of directors.]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/5-24-11drhillboardpressrelease.pdf</link>
    <pubDate>Tue, 24 May 2011 14:03:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces pre-IDE Meeting with FDA</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting with the U.S. Food and Drug Administration's]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/5-10-11FDE_Pre-IDEPressRelease.pdf</link>
    <pubDate>Tue, 10 May 2011 07:10:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Appoints Vice 
President, Business Development &amp; 
Marketing</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. 
(PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business 
Development &amp; Marketing. His employment begins shortly, and Company Executive VP,...]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/nr_2011_03_08.pdf</link>
    <pubDate>Tue, 08 Mar 2011 15:34:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Achieves Major Milestone</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: 
SBOTF) is pleased to announce successful completion of preclinical toxicity and 
immunogenicity testing of Stellar IMG KLH and Stellar Sub...]]></description>
    <link>http://www.stellarbiotechnologies.com//_resources/news/1-25-11milestonerelease.pdf</link>
    <pubDate>Tue, 25 Jan 2011 09:48:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Receives Extension of NSF - TECP Grant</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that its U.S. subsidiary has been awarded a $99,000 grant from The National Science Foundation (NSF)]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=56</link>
    <pubDate>Tue, 14 Dec 2010 14:38:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies' Exclusive License Agreement on Bayer Innovations/Stellar KLH Technology</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it has acquired an exclusive, irrevocable, worldwide, sub-licensable and royalty-free license to the techn...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=55</link>
    <pubDate>Tue, 07 Dec 2010 13:28:12 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies - Independent KLH Toxicity &amp; Immunogenicity Tests Complete</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) (www.StellarBiotechnologies.com) announces completion of preclinical toxicity and immunogenicity testing of Stellar KLH/SUBUNIT and St...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=52</link>
    <pubDate>Tue, 30 Nov 2010 07:12:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Closes CDN $3.7m Private Placement</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (the "Company" or "Stellar") (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it has closed the non-brokered private placement announced on October 25, 201...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=51</link>
    <pubDate>Mon, 15 Nov 2010 14:54:48 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces US $488,985 Award In U.S. IRS Therapeutic Discovery Grants</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (the "Company" or "Stellar", TSX.V: KLH - U.S. OTC: SBOTF) is pleased to announce that its California subsidiary received news this week that it has been awarded two g...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=50</link>
    <pubDate>Thu, 04 Nov 2010 07:02:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Announces $3.6 Million Private Placement</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (the "Company" or "Stellar", TSX.V: KLH) announces a non-brokered private placement financing consisting of up to 6,000,000 units (the "Units") at a purchase price of ...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=49</link>
    <pubDate>Mon, 25 Oct 2010 06:27:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies' Sub Invited to Submit Application by National Science Foundation (NSF) on Bayer Innovation Collaboration</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. announced today that its California subsidiary has been invited to submit a formal application for funding under the National Science Foundation's (NSF) Technology Enh...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=48</link>
    <pubDate>Wed, 20 Oct 2010 07:12:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Provides Quarterly Update/Outlook and Comments on CBS News Cancer Vaccine Story</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. ("Stellar" or "the Company") has been advancing on several fronts over their first quarter as a public company, and expects to achieve new milestones before year end. ...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=47</link>
    <pubDate>Wed, 13 Oct 2010 11:48:50 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Receives US$ 288,000 Payment</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. received payment of US$ 288,000 for a filled order of Stellar KLH/SUBUNIT from French biotechnology and active immunotherapy technology-platform company]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=46</link>
    <pubDate>Thu, 30 Sep 2010 06:26:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces CDN$ 1.05M Financing and Retires 1.66M Shares</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (Stellar) is pleased to announce that it has agreed to complete a CDN$ 1.05M private placement subject to acceptance by the TSX Venture Exchange]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=45</link>
    <pubDate>Wed, 29 Sep 2010 13:35:11 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces Achievement of Milestone in Cooperation with Bayer Innovation</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. is collaborating with Bayer Innovation GmbH (BIG) in the development of biopharmaceuticals.]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=44</link>
    <pubDate>Mon, 13 Sep 2010 06:31:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Files Key Patent for Company</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (PINK SHEETS: SBOTF &amp; TSX-V: KLH) announces filing for patent protection of inventions related to its native Immunogenic (IMG) KLH technology platform and immune statu...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=43</link>
    <pubDate>Thu, 09 Sep 2010 05:17:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Welcomes Malcolm Gefter, Ph.D. to Corporate and Scientific Advisory Boards</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. is pleased to announce that eminent biochemist, Malcolm Gefter, Ph. D. has accepted appointment to both Stellar's Board of Directors and to its Scientific Advisory Boa...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=41</link>
    <pubDate>Mon, 12 Jul 2010 11:48:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Appoints John S. Sundsmo, Ph.D. to VP, Research &amp; IP Management and Daniel C. Adelman, M.D. as Member of SAB</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) has appointed John S. Sundsmo, Ph.D., VP - Research &amp; Intellectual Property Management and Daniel C. Adelman, M.D. as a member of the Scienti...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=37</link>
    <pubDate>Tue, 29 Jun 2010 09:16:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Announces New Website - www.StellarBiotechnologies.com</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) is pleased to announce that it has released its new customer and investor-friendly website at www.StellarBiotechnologies.com.]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=38</link>
    <pubDate>Tue, 22 Jun 2010 09:18:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Beginning Preclinical</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) will initiate preclinical testing of its immunogenic agent, Stellar KLH/NeoA, in anticipation of filing an IND application for its Stellar KL...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=36</link>
    <pubDate>Thu, 10 Jun 2010 08:53:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Customer Finds Increased Uses for the Company's Key Product</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) ("Stellar") is pleased to announce that its long-term customer, Neovacs SA - Paris (Paris Alternext: ALNEV), recently reached significant mile...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=22</link>
    <pubDate>Tue, 01 Jun 2010 17:15:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Appoints Herbert S. Chow, Ph.D., VP - Product Development</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed Herbert S. Chow, Ph.D., VP: Product Development.]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=21</link>
    <pubDate>Tue, 18 May 2010 17:13:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Appoints Andrew Saxon, M. D., Chairman - Scientific Advisory Board (SAB)</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed Dr. Andrew Saxon, a world-renowned expert in human cellular and molecular immunology, Chairman - SAB. Dr. Saxon is Professor &amp; C...]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=20</link>
    <pubDate>Tue, 11 May 2010 17:12:00 PST</pubDate>   
    </item>
        <item>
    <title>Stellar Biotechnologies Appoints Daniel E. Morse, Ph. D., Director and VP</title>
    <description><![CDATA[Stellar Biotechnologies, Inc. (OTC: SBOTF, TSX-V: KLH) has appointed eminent scientist Daniel E. Morse, Ph. D. as Director and Executive VP: Science &amp; Technology effective April 19, 2010.]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=19</link>
    <pubDate>Wed, 28 Apr 2010 17:11:00 PST</pubDate>   
    </item>
        <item>
    <title>CAG Capital Completes QT: Becomes Stellar Biotechnologies</title>
    <description><![CDATA[CAG Capital Inc. (now Stellar Biotechnologies, Inc.) (OTC: SBOTF, TSX-V: KLH) (the "Company") is pleased to announce the closing of the acquisition of Stellar Biotechnologies, Inc.]]></description>
    <link>http://www.stellarbiotechnologies.com/investors/news_releases/index.php?&amp;content_id=18</link>
    <pubDate>Wed, 14 Apr 2010 17:07:00 PST</pubDate>   
    </item>
    
	</channel>
</rss>

